Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Lansoprazole[1] Lansoprazole (Lansoprazole-30)[1] Lansoprazole (Lansoprazole, LANSOPRAZOLE DR) 💬 [2] ATP4A,
ATP4B 💬 		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[7] 63, 71, 85, 98, 166, 222, 299 💬
2Lansoprazole 30mg[1] Lansoprazole (Lansoprazole-30)[1] Lansoprazole (Lansoprazole, LANSOPRAZOLE DR) 💬 [2] ATP4A,
ATP4B 💬 		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[1] 166 💬
3Lansoprazole, amoxicillin, clarithromycin[3] Amoxicillin (Aa-lansoprazole-amoxicillin-clarithromycin),
Clarithromycin (Aa-lansoprazole-amoxicillin-clarithromycin),
Lansoprazole (Lansoprazole-30)		[4] Amoxicillin ,
Clarithromycin ,
Lansoprazole (Lansoprazole, LANSOPRAZOLE DR),
Amoxicillin 💬 		[2] ATP4A,
ATP4B 💬 		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[1] 222 💬
4Lansoprazole, clarithromycin, amoxycillin[3] Amoxicillin (Aa-lansoprazole-amoxicillin-clarithromycin),
Clarithromycin (Aa-lansoprazole-amoxicillin-clarithromycin),
Lansoprazole (Lansoprazole-30)		[4] Amoxicillin ,
Clarithromycin ,
Lansoprazole (Lansoprazole, LANSOPRAZOLE DR),
Amoxicillin 💬 		[2] ATP4A,
ATP4B 💬 		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[1] 63 💬
5Treat with lansoprazole 30 mg BID for 2 weeks, endoscopic examination with esophageal biopsy for patients with persistent symptoms[1] Lansoprazole (Lansoprazole-30)[1] Lansoprazole (Lansoprazole, LANSOPRAZOLE DR) 💬 [2] ATP4A,
ATP4B 💬 		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[1] 98 💬